Lantheus Holdings Shares Outstanding 2013-2025 | LNTH
- Lantheus Holdings shares outstanding for the quarter ending March 31, 2025 were 0.071B, a 1.95% increase year-over-year.
- Lantheus Holdings 2024 shares outstanding were 0.072B, a 2.01% increase from 2023.
- Lantheus Holdings 2023 shares outstanding were 0.07B, a 0.61% decline from 2022.
- Lantheus Holdings 2022 shares outstanding were 0.071B, a 4.72% increase from 2021.
Lantheus Holdings Annual Shares Outstanding (Millions of Shares) |
|
---|---|
2024 | 72 |
2023 | 70 |
2022 | 71 |
2021 | 67 |
2020 | 54 |
2019 | 40 |
2018 | 40 |
2017 | 39 |
2016 | 33 |
2015 | 24 |
2014 | 18 |
2013 | 18 |
2012 | 50 |
Lantheus Holdings Quarterly Shares Outstanding (Millions of Shares) |
|
---|---|
2025-03-31 | 71 |
2024-12-31 | 72 |
2024-09-30 | 73 |
2024-06-30 | 71 |
2024-03-31 | 70 |
2023-12-31 | 70 |
2023-09-30 | 70 |
2023-06-30 | 71 |
2023-03-31 | 68 |
2022-12-31 | 71 |
2022-09-30 | 71 |
2022-06-30 | 71 |
2022-03-31 | 70 |
2021-12-31 | 67 |
2021-09-30 | 68 |
2021-06-30 | 68 |
2021-03-31 | 68 |
2020-12-31 | 54 |
2020-09-30 | 67 |
2020-06-30 | 43 |
2020-03-31 | 40 |
2019-12-31 | 40 |
2019-09-30 | 40 |
2019-06-30 | 40 |
2019-03-31 | 40 |
2018-12-31 | 40 |
2018-09-30 | 39 |
2018-06-30 | 39 |
2018-03-31 | 39 |
2017-12-31 | 39 |
2017-09-30 | 39 |
2017-06-30 | 39 |
2017-03-31 | 39 |
2016-12-31 | 33 |
2016-09-30 | 32 |
2016-06-30 | 31 |
2016-03-31 | 30 |
2015-12-31 | 24 |
2015-09-30 | 31 |
2015-06-30 | 19 |
2015-03-31 | 18 |
2014-12-31 | |
2014-09-30 | 18 |
2014-06-30 | 18 |
2013-12-31 | |
2012-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $5.005B | $1.534B |
Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $218.750B | 25.66 |
Boston Scientific (BSX) | United States | $152.620B | 38.21 |
Stryker (SYK) | United States | $150.824B | 31.54 |
EssilorLuxottica (ESLOY) | France | $131.932B | 0.00 |
Medtronic (MDT) | Ireland | $117.545B | 16.66 |
Lonza Group Ag (LZAGY) | Switzerland | $49.596B | 0.00 |
Haleon (HLN) | United Kingdom | $43.351B | 24.74 |
ResMed (RMD) | United States | $39.208B | 29.45 |
GE HealthCare Technologies (GEHC) | United States | $35.024B | 16.63 |
Agilent Technologies (A) | United States | $33.005B | 21.52 |
Koninklijke Philips (PHG) | Netherlands | $24.092B | 16.91 |
Terumo (TRUMY) | Japan | $23.645B | 30.71 |
Insulet (PODD) | United States | $20.097B | 78.89 |
Zimmer Biomet Holdings (ZBH) | United States | $19.096B | 12.26 |
Baxter (BAX) | United States | $14.117B | 10.54 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.680B | 23.25 |
Perrigo (PRGO) | Ireland | $3.788B | 9.60 |
Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
Haemonetics (HAE) | United States | $3.565B | 16.24 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.397B | 28.23 |
ICU Medical (ICUI) | United States | $3.107B | 22.91 |
LeMaitre Vascular (LMAT) | United States | $1.816B | 40.60 |
QuidelOrtho (QDEL) | United States | $1.727B | 11.88 |
AtriCure (ATRC) | United States | $1.454B | 0.00 |
Acuren (TIC) | United States | $1.435B | 0.00 |
AdaptHealth (AHCO) | United States | $1.279B | 12.99 |
Green Thumb Industries (GTBIF) | United States | $1.243B | 27.96 |
Phibro Animal Health (PAHC) | United States | $1.185B | 15.15 |
Neogen (NEOG) | United States | $1.090B | 13.94 |
BioLife Solutions (BLFS) | United States | $1.024B | 0.00 |
InMode (INMD) | Israel | $0.911B | 9.18 |
Kestra Medical Technologies (KMTS) | United States | $0.874B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.791B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.784B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.644B | 0.00 |
Owens & Minor (OMI) | United States | $0.626B | 5.19 |
Evolus (EOLS) | United States | $0.617B | 0.00 |
CeriBell (CBLL) | United States | $0.561B | 0.00 |
Valneva SE (VALN) | France | $0.530B | 0.00 |
ZimVie (ZIMV) | United States | $0.522B | 23.71 |
Surmodics (SRDX) | United States | $0.456B | 0.00 |
SNDL (SNDL) | Canada | $0.431B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.312B | 11.48 |
Cresco Labs (CRLBF) | United States | $0.307B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.298B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.284B | 84.17 |
Quanterix (QTRX) | United States | $0.275B | 0.00 |
Cerus (CERS) | United States | $0.273B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.258B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.257B | 21.67 |
Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
Brainsway (BWAY) | Israel | $0.229B | 60.50 |
Biote (BTMD) | United States | $0.225B | 6.34 |
Verano Holdings (VRNOF) | United States | $0.220B | 0.00 |
Omeros (OMER) | United States | $0.219B | 0.00 |
Organigram Global (OGI) | Canada | $0.208B | 0.00 |
High Tide (HITI) | Canada | $0.195B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
TriSalus Life Sciences (TLSI) | United States | $0.170B | 0.00 |
Vireo Growth (VREOF) | United States | $0.153B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
FitLife Brands (FTLF) | United States | $0.124B | 15.32 |
TerrAscend (TSNDF) | Canada | $0.112B | 0.00 |
Jin Medical (ZJYL) | China | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.099B | 12.77 |
MacroGenics (MGNX) | United States | $0.097B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
Apyx Medical (APYX) | United States | $0.085B | 0.00 |
Veru (VERU) | United States | $0.084B | 0.00 |
Safety Shot (SHOT) | United States | $0.081B | 0.00 |
Zynex (ZYXI) | United States | $0.074B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Agape ATP (ATPC) | $0.068B | 0.00 | |
Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.062B | 0.00 |
United-Guardian (UG) | United States | $0.044B | 15.11 |
Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
Nephros (NEPH) | United States | $0.037B | 50.14 |
Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |